Alcoa Corporation (NYSE: AA) is slated to report fourth quarter 2019 earnings results on Wednesday, January 15, after the market closes. Analysts have projected a loss of $0.22 per share. This is a sharp drop from earnings of $0.66 per share last year. Revenue is also expected to decline over 25% year-over-year to $2.48 billion.
Alcoa has been struggling with weak demand and a tough macroeconomic environment. The company has been taking measures to lower costs and improve profitability. In October, the company said it was reviewing 4 million metric tons of alumina capacity, or around 27% of its global refining capacity.
As part of these efforts, last month, Alcoa announced the closure of its Point Comfort alumina refinery in Texas. The company will incur restructuring charges of around $175 million, or $0.94 per share, related to the closure in Q4 2019. Starting this year, the closure is expected to yield annual net income improvement of approx. $15 million and cash savings of approx. $10 million compared to the curtailment costs.
Also read: Alcoa Q3 2019 Earnings Conference Call Transcript
At the start of this year, Alcoa announced the sale of its Gum Springs, Arkansas waste treatment facility to Veolia ES Technical Solutions for $250 million. The deal is expected to close in the first quarter of 2020. As announced last quarter, Alcoa is pursuing sales of non-core assets over a period of 12-18 months in order to generate cash of $500 million to $1 billion.
In the third quarter of 2019, Alcoa missed earnings estimates while revenues were in line with forecasts. Revenue fell 5% to $2.6 billion while adjusted EPS totaled $0.44.
Alcoa’s shares have fallen 31% over the past one year and 8% in the past one month. The stock has an average price target of $24.00.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company